SG Americas Securities
MYGN icon

SG Americas Securities’s Myriad Genetics MYGN Stock Holding History

SG Americas Securities’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$295K Sell
51,643
-222
-0.4% -$1.01K ﹤0.01% 2599
2026
Q1 		$233K Buy
51,865
+12,057
+30% +$62.8K ﹤0.01% 2570
2025
Q4 		$245K Buy
39,808
+10,424
+35% +$75.6K ﹤0.01% 2847
2025
Q3 		$212K Buy
+29,384
New +$174K ﹤0.01% 2717
2025
Q2 		– Sell
-14,066
Closed -$125K – 3357
2025
Q1 		$125K Buy
+14,066
New +$169K ﹤0.01% 2886
2024
Q4 		– Sell
-23,678
Closed -$649K – 3439
2024
Q3 		$649K Buy
+23,678
New +$641K ﹤0.01% 1458
2024
Q2 		– Sell
-21,805
Closed -$465K – 3143
2024
Q1 		$465K Sell
21,805
-12,615
-37% -$271K ﹤0.01% 1465
2023
Q4 		$659K Sell
34,420
-24,268
-41% -$420K 0.01% 1292
2023
Q3 		$941K Buy
58,688
+45,340
+340% +$863K 0.01% 1318
2023
Q2 		$309K Buy
13,348
+397
+3% +$8.66K ﹤0.01% 1602
2023
Q1 		$301K Sell
12,951
-6,526
-34% -$133K ﹤0.01% 2120
2022
Q4 		$283K Sell
19,477
-10,489
-35% -$195K ﹤0.01% 1969
2022
Q3 		$572K Sell
29,966
-23,023
-43% -$528K 0.01% 1430
2022
Q2 		$963K Buy
52,989
+14,050
+36% +$292K 0.01% 1326
2022
Q1 		$981K Sell
38,939
-31,611
-45% -$809K 0.01% 1443
2021
Q4 		$1.95M Buy
70,550
+17,105
+32% +$496K 0.01% 1099
2021
Q3 		$1.73M Buy
53,445
+47,999
+881% +$1.59M 0.01% 1413
2021
Q2 		$167K Sell
5,446
-46,297
-89% -$1.34M ﹤0.01% 2418
2021
Q1 		$1.58M Buy
51,743
+13,691
+36% +$389K 0.01% 1205
2020
Q4 		$752K Sell
38,052
-7,661
-17% -$124K ﹤0.01% 1706
2020
Q3 		$596K Buy
45,713
+28,125
+160% +$356K ﹤0.01% 1519
2020
Q2 		$199K Sell
17,588
-3,095
-15% -$44K ﹤0.01% 2868
2020
Q1 		$296K Sell
20,683
-178
-0.9% -$3.76K ﹤0.01% 2243
2019
Q4 		$568K Buy
20,861
+7,569
+57% +$208K 0.01% 1665
2019
Q3 		$381K Sell
13,292
-3,793
-22% -$111K ﹤0.01% 2027
2019
Q2 		$475K Buy
17,085
+2,607
+18% +$73.6K ﹤0.01% 1918
2019
Q1 		$481K Sell
14,478
-74,892
-84% -$2.28M ﹤0.01% 1873
2018
Q4 		$2.6M Buy
+89,370
New +$3.21M 0.02% 698
2018
Q3 		– Sell
-9,704
Closed -$363K – 3348
2018
Q2 		$363K Sell
9,704
-8,075
-45% -$273K ﹤0.01% 2230
2018
Q1 		$525K Buy
17,779
+11,106
+166% +$376K ﹤0.01% 1837
2017
Q4 		$229K Buy
6,673
+1,979
+42% +$66.8K ﹤0.01% 2354
2017
Q3 		$170K Buy
4,694
+777
+20% +$22.2K ﹤0.01% 2721
2017
Q2 		$101K Buy
+3,917
New +$83.2K ﹤0.01% 2916
2017
Q1 		– Sell
-17,968
Closed -$300K – 3466
2016
Q4 		$300K Sell
17,968
-1,867
-9% -$33.8K ﹤0.01% 2035
2016
Q3 		$408K Buy
19,835
+15,927
+408% +$404K ﹤0.01% 1890
2016
Q2 		$120K Sell
3,908
-3,914
-50% -$136K ﹤0.01% 2315
2016
Q1 		$293K Buy
7,822
+3,855
+97% +$145K ﹤0.01% 2007
2015
Q4 		$171K Sell
3,967
-3,113
-44% -$132K ﹤0.01% 2177
2015
Q3 		$265K Sell
7,080
-2,088
-23% -$74.1K ﹤0.01% 1288
2015
Q2 		$312K Buy
9,168
+4,992
+120% +$170K ﹤0.01% 1752
2015
Q1 		$148K Sell
4,176
-11,585
-74% -$415K ﹤0.01% 2057
2014
Q4 		$537K Sell
15,761
-3,605
-19% -$128K ﹤0.01% 1605
2014
Q3 		$747K Buy
19,366
+15,854
+451% +$592K ﹤0.01% 1277
2014
Q2 		$137K Sell
3,512
-389
-10% -$14.5K ﹤0.01% 2217
2014
Q1 		$133K Sell
3,901
-39,536
-91% -$1.22M ﹤0.01% 2103
2013
Q4 		$911K Buy
43,437
+28,920
+199% +$731K ﹤0.01% 1239
2013
Q3 		$341K Buy
+14,517
New +$412K ﹤0.01% 1845

Other funds holding MYGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SG Americas Securities's MYGN Position: Q2 2026 in Review

SG Americas Securities reduced its Myriad Genetics (MYGN) stake by 0.43% in Q2 2026, selling an estimated $1.01K and leaving 51,643 shares worth $295K. The position accounts for ﹤0.01% of the portfolio, ranked #2599.

SG Americas Securities first reported a position in MYGN in Q3 2013 and has held it in 47 quarters since. The position peaked at $2.6M in Q4 2018. 196 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.

  • SG Americas Securities held 51,643 shares of Myriad Genetics worth $295K as of Q2 2026.
  • SG Americas Securities sold 222 Myriad Genetics shares in Q2 2026, an estimated $1.01K.
  • Myriad Genetics made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #2599 holding.
  • SG Americas Securities first reported a position in Myriad Genetics in Q3 2013 and has held it in 47 quarters since.
  • SG Americas Securities's Myriad Genetics position peaked at $2.6M in Q4 2018.
  • 196 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.